Targeting prostate tumour and its stroma by nanoparticles

Area of Science:

• Oncology
• Nanotechnology
• Cancer Biology

Background:

• The tumor stroma, comprising immune and stromal cells, is crucial for prostate cancer (PCa) development.
• Stromal cells (fibroblasts, endothelial cells, stem cells) and immune cells (T cells, B cells, macrophages) significantly influence PCa growth.
• Targeting stromal components presents a promising strategy for PCa treatment.

Purpose of the Study:

• To review recent advancements in nanoparticle-based therapies targeting the prostate tumor stroma.
• To explore nanoparticle functionalization and targeting mechanisms for stromal elements in PCa.
• To evaluate the synergistic potential of combining nanoparticle therapies with conventional treatments.

Main Methods:

• Review of current literature on nanoparticle applications in PCa stroma.
• Analysis of organic and inorganic nanoparticle strategies for targeting fibroblasts, extracellular matrix (ECM), and immune cells.
• Evaluation of combination therapy approaches.

Main Results:

• Nanoparticles can be functionalized to specifically target stromal cells and ECM in PCa.
• Various nanoparticles demonstrate potential for precise delivery to prostate tumor microenvironment components.
• Combination therapies involving nanoparticles show synergistic potential for enhanced PCa treatment.

Conclusions:

• Nanoparticle-based strategies are emerging as effective tools for targeting the PCa stroma.
• Targeting stromal elements with nanoparticles offers a promising avenue for inhibiting PCa progression.
• Combining nanoparticle therapies with other treatments may improve therapeutic outcomes in prostate cancer.